Stocks of the Hour: Jindalee Lithium, Algorae Pharmaceuticals, Canyon Resources
Stocks of the Hour: Jindalee Lithium, Algorae Pharmaceuticals, Canyon Resources
To register for Friday's webinar click here.
請點擊此處註冊星期五的網絡研討會。
Jindalee Lithium (ASX:JLL) announced that battery-grade lithium carbonate has been successfully produced from ore from the McDermitt Lithium Project. All steps of the processing flowsheet for the Project from ore beneficiation and leaching to purification and production of battery-grade lithium carbonate are now validated. Shares are trading 13.46 per cent higher at 29.5 cents.
Jindalee鋰礦(ASX:JLL)宣佈,成功從McDermitt鋰礦項目的礦石中生產出電池級碳酸鋰。該項目從礦石選礦、浸出、純化到生產電池級碳酸鋰的所有過程都已經驗證。股價上漲13.46%,報0.295澳元。
Algorae Pharmaceuticals (ASX:1AI) has released positive results for its drug AI-116. It showed significantly better results in reducing brain cell damage than an existing dementia drug in laboratory tests. Shares are trading 33.33 per cent higher at 1.2 cents.
Algorae製藥公司(ASX:1AI)發佈了其AI-116藥物的積極成果。在實驗室測試中,它顯示出比現有的治療癡呆症的藥物在減輕大腦細胞損傷方面有顯著更好的效果。股價上漲33.33%,報0.012澳元。
Canyon Resources (ASX:CAY) has signed a mining convention for the Minim-Martap Bauxite Project in Cameroon. This agreement outlines how Canyon's subsidiary can mine and export alumina and bauxite once it receives a mining permit. Shares are trading 2.67 per cent higher at 7.7 cents.
Canyon資源(ASX:CAY)已經爲喀麥隆Minim-Martap鋁土礦項目簽署了採礦公約。協議規定,在Canyon的子公司獲得採礦許可證後,可以採礦和出口鋁土和氧化鋁。股價上漲2.67%,報0.077澳元。